They analyzed total EVs preparations obtained from serum instead of enriched ODEVs and compared the concentrations of myelin proteins, including MBP and MOG, in RRMS, secondary progressive (SP)MS and HC. The gene discussed is MOG; the disease is myeloid sarcoma.